Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

08. Mai 2025 13:00 ET | Quelle: DelveInsight Business Research LLP

High- and Low-Grade Serous Ovarian Cancer Market is Predicted to Grow at a CAGR of 7.9% During the Study Period (2020–2034) | DelveInsight

New York, USA, May 08, 2025 (GLOBE NEWSWIRE) -- High- and Low-Grade Serous Ovarian Cancer Market is Predicted to Grow at a CAGR of 7.9% During the Study Period (2020–2034) | DelveInsight As per...
14. September 2021 20:00 ET | Quelle: DelveInsight Business Research LLP

Ovarian Cancer Clinical Trials | A Drug Pipeline Analysis Report 2021 | DelveInsight

Los Angeles, USA, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Ovarian Cancer Clinical Trials | A Drug Pipeline Analysis Report 2021 | DelveInsight Around 100+ key companies are developing therapies for...
22. Oktober 2007 19:00 ET | Quelle: Marshall Edwards, Inc.

European Symposium on Phenoxodiol as an Investigational Drug for Ovarian Cancer Management

SYDNEY, AUSTRALIA and BERLIN and NEW CANAAN, CT--(Marketwire - October 22, 2007) - A symposium on platinum resistant ovarian cancer will be held at the European Society for Gynecological Oncology in...